Joan Mannick

Videos Mentioning Joan Mannick

175 - The biology of aging, rapamycin, and other interventions that target the aging process

Peter Attia MD

A researcher who conducted clinical trials with everolimus (a rapamycin derivative) at Novartis, showing its ability to boost vaccine response in older adults, and later involved with RestoreBio.

#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19

Peter Attia MD

Co-founder and Chief Medical Officer of Restore Biotherapeutics, trained in infectious disease, and an expert in Rapamycin analogs.

Dr. Peter Attia — Longevity Drugs, Alzheimer's Disease, and More

Tim Ferriss

Lead author on a 2014 study for Everolimus (a Rapamycin derivative) showing an improved immune response in 65-year-olds, counteracting expected immune-suppressing effects.

300-Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, & more

Peter Attia MD

Guest on a previous podcast episode discussing short-term human studies on Rapamycin.

Supplements for Longevity & Their Efficacy | Dr. Peter Attia

Andrew Huberman

Researcher who published a paper in 2014 demonstrating that everolimus enhanced immunity.

"Anti-Aging" Drugs — NAD, metformin, & rapamycin | The Peter Attia Drive Podcast (Ep 207, AMA 35)

Peter Attia MD

Mentioned as a past podcast guest discussing aging.